|
Designated Public Office Holders who participated in the communication:
|
Mark Holland,
Minister of Health
Health Canada (HC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Economic Development,
Health
|
Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.
|
|
Health
|
To actively promote the enhancement of publicly funded women’s health initiatives and programs, including the development of a Pan Canadian Women’s Health Strategy.
|
|
| |
|
Responsible Officer who filed this communication report:
|
Michael Casia
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
